Opinion
Zuranolone: A novel postpartum depression treatment, with lingering questions
It is noteworthy that while zuranolone received FDA approval for the PPD indication, it did not receive approval for the treatment of major...
Opinion
Transcranial magnetic stimulation during pregnancy: An alternative to antidepressant treatment?
A growing number of women ask about nonpharmacologic approaches for either the treatment of acute perinatal depression or for relapse prevention...
Opinion
Canadian Task Force recommendation on screening for postpartum depression misses the mark
The task force recently recommended against screening with systematic questionnaires, noting that benefits were unclear and not a particular...
Opinion
Long-term behavioral follow-up of children exposed to mood stabilizers and antidepressants: A look forward
Both antidepressants and newer mood stabilizers have been shown to be safe in pregnancy.
Opinion
Postpartum psychosis: Does longitudinal course inform treatment?
The good news is we’ve seen an evolution of both interest and expertise in acute management of postpartum psychosis and a richer appreciation of...
Opinion
Knowns and unknowns about SSRI use during pregnancy in 2022
Although some of the data remain incomplete, in 2022, patients will continue to make individual decisions factoring in the effect of maternal...
Opinion
Things reproductive psychiatrists might ‘always’ or ‘never’ do in 2022
In reproductive psychiatry, we tend to apply available data and clinical experience as we guide patients on a case-by-case basis.
News
Toward a clearer risk model for postpartum psychosis
Despite the growing, appropriate focus on recognition and acute treatment of postpartum depression as well as assessing clinical outcomes for...
Opinion
Reproductive safety of treatments for women with bipolar disorder
Women with bipolar disorder are at particular risk for postpartum worsening of their mood and we have noticed during the pandemic that women are...
Opinion
Reproductive psychiatry in 2021: Old questions and new challenges
The level of anxiety associated with decisions to sustain or to discontinue treatment during pregnancy seems to have increased for some patients...
Opinion
Treating insomnia, anxiety in a pandemic
We have unequivocally seen a worsening of complaints of sleep disruption including insomnia and midcycle awakening during the pandemic.
Opinion
Mitigating psychiatric disorder relapse in pregnancy during pandemic
The most common reasons for consultation on our service continue to be the appropriate, safest use of antidepressants and mood stabilizers during...
Opinion
Understanding postpartum psychosis: From course to treatment
Postpartum psychosis is relatively rare, with an incidence of 1 in 1,000 births, but it is one of the most serious complications of modern...
Opinion
Zulresso: Hope and lingering questions
Where does brexanolone fit into the algorithm for treating women who suffer from postpartum depression?